等待开盘 03-27 09:30:00 美东时间
+0.050
+2.54%
Co-Diagnostics expands CoSara's reach across South Asia, targeting a $13 billion market and boosting access to rapid diagnostic solutions.
03-20 19:56
Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that on March 9, 2026,
03-10 21:10
Maxim Group analyst Jason McCarthy downgrades Co-Diagnostics (NASDAQ:CODX) from Buy to Hold.
01-24 02:27
HC Wainwright & Co. analyst Yi Chen reiterates Co-Diagnostics (NASDAQ:CODX) from Neutral to Neutral.
2025-11-24 20:31
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
2025-11-13 19:11
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gai...
2025-10-29 00:18
Co-Diagnostics (CODX) stock falls over 50% as they announced a $7 million offering and Saudi joint venture, causing concerns about dilution.
2025-10-28 23:50
U.S. stocks traded higher this morning, with the Dow Jones index gaining more t...
2025-10-28 21:57
Codexis to attend Jefferies Global Healthcare Conference on June 3-5, 2025, with management participating in a fireside chat on June 4 at 3:10 pm ET. A live webcast and 90-day replay will be available on the company’s Investor Relations website.
2025-05-21 20:05